Advanced Filters
noise

Aarhus, Jylland, Denmark Clinical Trials

A listing of Aarhus, Jylland, Denmark clinical trials actively recruiting patients volunteers.

Found 273 clinical trials
F Frank V Mortensen, MD, DMSc

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

The aim of the study is to examine the incremental value of using magnetic resonance imaging (MRI) in addition to computed tomography (CT) in the diagnostic workup of pancreatic cancer patients.

18 - 99 years of age All Phase N/A
H Helene Nørrelund

Comparative Study of High-Efficacy Disease Modifying Treatment of Relapsing Multiple Sclerosis

The goal of this prospective, multi-center, non-blinded, non-randomized, non-intervention clinical trial is to compare immunologic, virologic and epigenetic factors in patients with active multiple sclerosis in standard 2.line treatment with ocrelizumab, rituximab, ofatumumab or natalizumab in Region Midt, Denmark. It aims to answer how the immunologic, virologic and epigenetic response …

18 - 65 years of age All Phase N/A
K Karen Louise Thomsen, PhD

Faecal Microbiota Transplantation for Liver Cirrhosis

The purpose is to investigate the effect of faecal microbiota transplantation (FMT) on complications, progression, and mortality of patients with liver cirrhosis. Further, the investigators want to examine the impact of FMT on the gut microbiota, gut barrier function, systemic inflammation, and immune function.

18 - 75 years of age All Phase 2/3

Paediatric Autism Communication Therapy (PACT) in Children With Autism Spectrum Disorder

Paediatric Autism Communication Therapy (PACT) is a naturalistic developmental behavioural interventions to reduce autism symptoms. The aim of this trial is to assess the beneficial and harmful effects of PACT in 2-6 year-old children with a recent diagnosis of autism spectrum disorder.

2 - 6 years of age All Phase N/A

Gastrointestinal Stimulation as a Treatment of Postoperative Ileus Following Extensive Surgery

The goal of this clinical trial is to investigate the effect of gastrointestinal stimulation with a pacemaker on the length of postoperative bowel paralysis in patients undergoing major abdominal surgery due to metastasizing colorectal cancer, appendiceal cancer or pseudomyxoma peritonei. The main question it aims to answer is if the …

18 years of age All Phase N/A
M Mona Kristiansen, MD

18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the most common primary liver tumor and the fourth leading cause of cancer-related death worldwide. In Denmark, the incidence of HCC is 5.2 per 100.000 population per year with a dismal prognosis as the median survival time is just 7.7 months. Extrahepatic spread of HCC is …

18 - 100 years of age All Phase N/A

Coronary Computed Tomography Angiography For Optimized Invasive Coronary examInation

Coronary computed tomography angiography (CCTA) is a non-invasive method for visualization of the coronary arteries. The anatomical information obtained by CCTA, however, is rarely integrated into a subsequent coronary intervention. The CT-FOCI trial aims to evaluate, in a randomized setting, the benefit of implementing the information obtained by CCTA as …

18 - 80 years of age All Phase N/A
J Janni K Thillemann, Dr

Danish Multicenter Scapholunate Ligament Study

Comparison of two surgical techniques commonly used for reconstruction of the scapholunate (SL) ligament. A randomized multicenter study.

18 - 60 years of age All Phase N/A
V Vivi Mäkinen

The Optimised Use of Romozosumab Study

OPTIMIST is a two-year, randomised, active controlled, open-label, multicentre intervention trial. OPTIMIST includes 3 treatment groups each comprising combinations of romosozumab (ROMO) and zoledronate (ZOL) treatment used in standard doses (210 mg monthly (sc) and 5 mg yearly (iv), respectively). The study will investigate if it is possible to maximize …

50 years of age Female Phase 4
L Lars Markvardsen, MD

Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)

SIDEC - (Subcutaneous Immunoglobulin in De-novo CIDP) ia a study designed as a randomized, parallel study with an open-label extension phase. The aims are to compare the effect of SCIG and IVIG in 60 treatment-naïve CIDP patients, and to detect the lowest effective dosage for maintenance treatment.

18 years of age All Phase 4

Simplify language using AI